Mecka | $60,000,000 | (Jun 3, 2026)
Novellia | $18,000,000 | (Jun 3, 2026)
Plot | $10,000,000 | (Jun 3, 2026)
Certified by Founder
Lodge
ExcepGen
start up
United States
- San Francisco, CA
- 25/08/2023
- Unknown
- $4,000,000
ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new generation of therapeutics.
- Industry Biotechnology Research
- Website https://www.excepgen.com/
- LinkedIn https://www.linkedin.com/company/excepgen/about/
Related People
Thomas FolliardCo Founder
United States -
San Francisco, California
I am involved in a variety of activities and responsibilities having to do with making drugs easier to discover.
Specialties: foundational engineering of biology, next-generation drugs and drug discovery, starting organizations.
Phosio Corporation | $4,000,000 | (Jun 3, 2026)
StratusGrid | $3,000,000 | (Jun 3, 2026)
Subtle Medical | $33,000,000 | (Jun 3, 2026)
Tavo Biotherapeutics | $17,000,000 | (Jun 3, 2026)
Contraline | $92,500,000 | (Jun 3, 2026)
Gigaton | $26,000,000 | (Jun 3, 2026)
Westmag | $11,000,000 | (Jun 3, 2026)
Inherent | $50,000,000 | (Jun 2, 2026)